No benefit to adding limited radiation in advanced cancerJuly 11, 2023Lung CancerMelanomaGenitourinary CancerHead & Neck/Thyroid Cancers
Cancer Data Trends 2023July 5, 2023Breast CancerGenitourinary CancerLung CancerProstate CancerColon and RectalMelanoma
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaAML
CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Huge underuse of germline testing for cancer patientsJune 22, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncologyJune 15, 2023Mixed TopicsBreast CancerMelanomaGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Lung CancerBreast CancerGenitourinary CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid Cancers
Risk of falls seen with newer antiandrogens for prostate cancerJune 9, 2023Genitourinary CancerProstate Cancer
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Lung CancerOncologyBreast CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid Cancers
